Question 1

What is GT Biopharma?

Accepted Answer

GT Biopharma is a Company.

Question 2

How often does GT Biopharma appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 27 articles.

Question 3

When was GT Biopharma first tracked by Ergen?

Accepted Answer

First tracked on Apr 02, 2026.

Question 4

When was GT Biopharma last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is GT Biopharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is GT Biopharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving GT Biopharma?

Accepted Answer

Crescent Biopharma Grants Equity Awards (May 29, 2026, 8 articles).

Question 8

Who is GT Biopharma most connected to?

Accepted Answer

Top relationships: European Union — European Medicines Agency, European Union — European Medicines Agency, United States — Food and Drug Administration.

Question 9

How did the "Crescent Biopharma Grants Equity Awards" event impact GT Biopharma?

Accepted Answer

GT Biopharma granted equity inducement awards to new non-executive employees, which is a positive move for employee retention and attracting talent, potentially boosting its stock price.

Question 10

How did the "SERB_Pharmaceuticals acquires Idefirix rights" event impact GT Biopharma?

Accepted Answer

GT Biopharma>>> divested the European and MENA rights to Imlifidase for 115 million euros, allowing it to focus on other markets and receive significant payments.

Question 11

How did the "Splash_Beverage_Group Licenses CannEpil Globally" event impact GT Biopharma?

Accepted Answer

GT Biopharma licensed its CannEpil therapeutic to Splash Beverage Group globally. GT Biopharma will receive a 15% royalty on net revenue from worldwide sales of CannEpil and had approximately $5 million of its indebtedness forgiven by Mercer Street Global Opportunity Fund.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.